Consistent with the change in circulating immune cell counts, there was no significant change in immune cell count or the CD4+/CD8+ ratio in periablational tumor tissues after 30 min of treatment with iRFA (Fig. 2C and F, p > 0.05). Here, CD8A is linked to neoplasm.